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Abstract 
Background: Maternal morbidity and mortality has been a major World Health Organization concern over the years, 
especially in sub‑Saharan Africa. This paper reports uterine rupture with severe hypovolemic shock managed at the 
Douala General Hospital, Cameroon. Early clinical diagnosis is paramount to maternal survival.
Case presentation: Mrs. MM aged 25 years, G3P2012, of the Bamileke tribe in Cameroon was admitted to our 
Department in hypovolemic shock BP = 70/40 mmHg, pulse 120 beats per minute, with altered consciousness 
(Glasgow Coma Scale = 13). She has a history of missed abortion at 19 weeks gestation and an attempt to evacuate 
the uterus with misoprostol that led to uterine rupture. She underwent a total abdominal hysterectomy and blood 
transfusion. Her post‑operative stay in hospital was uneventful.
Conclusion: Uterine rupture is a complication that can be eliminated under conditions of best obstetric practice. To 
attain this objective, use of misoprostol in primary health facilities should be stopped or proper management of the 
medication instituted. The survival of patients after uterine rupture depends on the time interval between rupture 
and intervention, and the availability of blood products for transfusion.
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Background
Maternal mortality, one of the major concerns of the 
World Health Organization, remains high in most of sub-
Saharan Africa [1, 2]. In the particular case of Mezam 
Division, Cameroon, the leading causes are Postpartum 
Hemorrhage (30.43%), unsafe abortion (26.09%), and 
pregnancy-induced hypertension (14.49%) [1, 2].
Misoprostol is a prostaglandin E1 analog that was orig-
inally used for the prevention and treatment of peptic 
ulcer disease [3]. It has been recently used in the treat-
ment of post-partum hemorrhage and complications of 
abortion [4]. The optimal dose for this medication has 
been a controversial issue and practitioners, especially 
those with little or no experience with the manipulation 
of this medication, sometimes have difficulties that could 
lead to life-threatening consequences like uterine rupture 
[5].
We are reporting a case of uterine rupture for second 
trimester evacuation of a dead fetus that was managed 
at the department of Obstetrics and Gynecology, Douala 
General Hospital, Cameroon.
Case presentation
Mrs. MM aged 25 years, G3P2012, of the Bamileke tribe 
in Cameroon was admitted to our Department in hypo-
volemic shock BP =  70/40  mmHg, pulse 120 beats per 
minute with altered consciousness (Glasgow Coma 
Score  =  13). She has a history of missed abortion at 
19 weeks gestation diagnosed by ultrasonography 3 days 
prior to admission at our Department, and an attempt 
to evacuate the uterus with an unknown dose of mis-
oprostol before she went into shock. At the time of the 
uterine evacuation, the pregnancy was 24  weeks 2  days 
gestation calculated from her last menstrual period. On 
examination, the conjunctivae were pale and the pulse 
rate 120 beats per minute. The abdomen was distended 
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and tender on palpation. There was a fluid thrill, shifting 
dullness and mild vaginal bleeding. An emergency posi-
tive culdocentesis was done.
During this period, the anesthesiologist had been called 
who secured an intravenous line with a 14 G catheter, 
obtained blood for Full blood count, coagulation studies, 
typing and cross match. 1500  mL of blood was secured 
from the laboratory and she underwent an emergency 
laparotomy with a sub-umbilical mid-line incision.
During surgery, we found that there was hemop-
eritoneum estimated at about 2500  mL and the uterus 
was completely torn posteriorly from the fundus to 
the isthmus and extending to the left broad ligament 
with involvement of the ascending branch of the uter-
ine artery (Figs.  1, 2). The fetus was found in the peri-
toneal cavity completely macerated. We carried out a 
total abdominal hysterectomy and peritoneal toileting. 
The patient was transfused 1500  mL of whole blood 
during surgery. She was then transferred to the inten-
sive care unit (ICU) where she was followed up for 48 h. 
Her hemoglobin level the day after surgery was 6.4  g/
dL. She received a further 1000 mL of packed cells at the 
ICU, making a total of 2500  mL blood received by the 
patient. She remained at the Department of Obstetrics 
and Gynecology for 5 more days and her hemoglobin 
level on discharge was 8.1 g/dL. Patient was discharged 
on hematinics and vitamins.
Conclusions
Maternal mortality has been one of the millennium 
development goals (MDG 5) and although progress has 
gradually been made in reducing maternal mortality, 
action is needed to meet the sustainable development 
goal (SDG) 2030 target [6]. Uterine rupture and maternal 
death from hemorrhage is a preventable complication of 
childbirth in sub-Saharan Africa.
Prevalence of uterine rupture
Uterine rupture is a serious obstetrical condition associ-
ated with maternal mortality. In a systematic review by 
Justus Hofmeyr et  al., uterine rupture was reported to 
be lower in a community-based study (median 0.053%, 
range 0.016–0.030%) compared to facility-based study 
(0.031, 0.012–2.9%). This prevalence was also higher 
in less developed countries (sub-Saharan Africa espe-
cially) than in the developed countries [7]. Prual et al. in 
a case fatality study of maternal morbidity from 23 West 
African countries and 20326 pregnant women between 
32 and 36  weeks amenorrhea during delivery and up 
to 60  days post partum reported that uterine rupture 
accounted for 0.12 per 100 live births [8]. Nguefack et al. 
in Douala reported that the prevalence of uterine rupture 
was 0.4% (1:249) [9]. Another study in Ethiopia reported 
a prevalence of 0.9% [10].
Vaginal birth after cesarean
There is a steady decrease in the rate of vaginal birth after 
cesarean (VBAC) [11]. In a study in Ghana, a fetal weight 
greater than 3.45  kg tripled the likelihood of having a 
Uterine rupture involving the left broad ligament and 
posterior uterus (See arrows)
Fig. 1 Posterior uterine rupture extending from the fundus to the 
isthmus and affecting the left broad ligament and uterine vessels 
(See arrows)
Posterior Uterine Rupture from fundus to isthmus
Fig. 2 Posterior wall uterine rupture extending from the fundus to 
the isthmus
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repeat cesarean delivery (CD), and the probability of 
having a repeat CD was 50% for a fetal weight of 3.70 kg 
[12, 13]. This fact should be considered when counseling 
women for VBAC [13].
The increasing number of women with a previous 
cesarean section and the decreasing rates of VBAC seem 
to suggest that cesarean sections are gaining more cur-
rency. One of the greatest concerns regarding VBAC is 
the potential for uterine rupture. Studies have reported 
that the incidence rate of uterine rupture in women who 
attempt VBAC was 9.8 per 1000 and prior vaginal deliv-
ery was associated with a lower risk of uterine rupture 
(adjusted odds ratio [OR] 0.40, 95% CI 0.20–0.81) [14].
Use of oxytocin and prostaglandins
With the advent of misoprostol, a prostaglandin E1 analog 
is cheap and accessible to most health facilities in Cam-
eroon and most countries in sub-Saharan Africa. As a 
result, the rates of uterine rupture have increased noticea-
bly. The study by Nguefack et al. reported that 71% of cases 
with uterine rupture used misoprostol [9]. Studies in Bang-
ladesh and India report the use of oxytocin by unqualified 
allopathic practitioners (UAP) providing health services 
to the poor [15]. These providers are close to homes, will-
ing to make house calls, trusted by the community, have 
longer working hours and offer services at lower costs. 
UAPs, comprising village doctors (VDs) and unlicensed 
drug sellers, have limited training of a few weeks to a few 
months from semiformal private institutions, focused on 
common illnesses and diseases, and rarely on labour or 
delivery. These training institutions are unregulated and 
do not follow a standard [15]. This type of practice should 
be discouraged because it is associated with obstetric and 
neonatal complications such as uterine rupture [15].
Partogram use
Health personnel are almost forgetting the good practice of 
using the partogram for labor follow-up. Egbe et al. in the 
Bamenda Health District, Cameroon, showed that 58.2% 
deliveries were followed up with the partogram, only 1% of 
which were filled to standard [16]. Wacker et al. in Burkina 
Faso reported 46.6% partogram use [17] while Ogwang 
et  al. in Rukungiri District in Uganda reported 30% use 
[18]. These low rates of partogram use could have obstet-
ric consequences, especially given the high likelihood that, 
under such circumstances, parturients are administered 
oxytocin or prostaglandins and are not properly followed 
up by hourly or two-hourly examinations.
Cervical ripening with a trans‑cervical foley
In a study of patients with a prior cesarean being induced 
with the trans-cervical foley bulb, the rate of uterine 
rupture was 1.1% with spontaneous labor, 1.2% with 
induction with amniotomy, and 1.6% with use of a trans-
cervical Foley bulb. Therefore, labor induction using a 
trans-cervical Foley catheter was not associated with an 
increased risk of uterine rupture [19]. This may have been 
the appropriate method for our patient although she was 
at no particular risk of uterine rupture.
Inter‑pregnancy interval
Several studies have shown that the shorter the time 
between a cesarean delivery and a subsequent delivery, 
the higher the rate of uterine rupture. Commonly, thresh-
olds of 18 and 24 months have been examined. Adjusted 
odds ratios range from 2.5 to 3 for an increased rate of 
uterine rupture in the women with less time between 
deliveries. The biologic plausibility of this effect is related 
to the amount of time required for the uterine scar to 
heal completely and to nutritional Factors [20–22].
Hysterotomy technique
Women with a classical incision that run vertically on 
the corpus uteri run a higher risk of uterine rupture than 
those with a low uterine segment transverse incision [23]. 
Patients with a classical hysterotomy are likely to rup-
ture during pregnancy and studies have shown that they 
should be delivered by 36–37 weeks gestation. However, 
others suggest a planned cesarean delivery at 38  weeks 
gestation [24]. Furthermore, a single-layer closure of the 
previous lower segment incision is the most influential 
factor and is associated with a fourfold increase in the 
risk of uterine rupture compared with a double-layer clo-
sure [25].
Uterine rupture in unscarred uterus
In a study of 32 080 deliveries in JIPMER (India), 93 
(0.28%) women had a ruptured uterus. The major-
ity (77%) had a scarred uterus. Among women with 
unscarred uterus, 14 presented with rupture and seven 
of these women were induced in hospital. It was then 
concluded that the strongest association of ruptured 
uterus was with previous scarred uterus, multiparity 
and <18 months’ duration from the last cesarean section 
[26]. In another population-based study in the Nether-
lands, the incidence of uterine rupture was comparable 
with other Western countries. Although much attention 
is paid to scar rupture associated with uterotonic agents, 
13% of ruptures occurred in unscarred uteri and 72% 
occurred during spontaneous labour [27].
Reports from the study in Mali show that uterine rup-
ture occurred in 87.4% (415/475) of cases in an unscarred 
uterus vs 12.6% (60/475) in a scarred uterus. Observed 
risk factors for primary uterine rupture included: con-
tracted pelvis, 12.0% (57/475); fetal macrosomia 9.7% 
(46/475); contracted pelvis associated with macrosomia 
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3.4% (16/475). Malpresentation was recorded in 12.4% 
(59/475). Dystocia associated with oxytocin and/or tradi-
tional medicines labor augmentation has been observed 
in 12.6% of cases (60/475). Grand multiparity (≥7 deliv-
eries in obstetric history) accounted for 12.4% (59/475) 
of all uterine ruptures while short inter-pregnancy inter-
val has been observed in 12.0% of all uterine ruptures 
(57/475) [28].
Our patient was not at particular risk for uterine rup-
ture. She was administered misoprostol to effect uterine 
evacuation of a dead fetus in a primary care centre with 
no facilities or skilled personnel to carry out a cesar-
ean section. The patient would have lost her life had 
intervention not been prompt. She owed her life to her 
timely action. She came to our Department relatively 
early, about 30 min after the incident, and we intervened 
immediately, aided by the fact that compatible blood was 
available in the blood bank.
Uterine rupture is a clinical diagnosis and there must 
be a high index of suspicion by the healthcare provider. 
Risk factors for such ruptures may include previous uter-
ine scar, short birth spacing, and use of uterotonic (oxy-
tocin/prostaglandin) medications [9, 29, 30]. A scarred 
uterus is not a necessary pre-condition for uterine rup-
ture. Turner et  al. reported that uterine rupture in the 
majority of cases is associated with poor and traumatic 
obstetric practice [31]. Our patient was administered 
an unknown dosage of misoprostol that resulted in the 
rupture.
This case stresses the importance of good obstetric 
practice and the need for qualified medical and paramed-
ical staff. It cautions that medications like oxytocin and 
prostaglandins should be manipulated under specialized 
care and, finally, that health establishments should not 
handle deliveries unless they are equipped for the com-
plications of labour and delivery.
Finally, uterine rupture is a complication that can be 
eliminated if best obstetric practice is ensured. The sur-
vival of patients after uterine rupture depends on the 
time interval between rupture and intervention and the 
availability of blood products for transfusion. CARE 
guidelines/methodology were adhered to in the prepara-
tion of this manuscript.
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